2.85
-0.01 (-0.35%)
-0.01 (-0.35%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.01 | -0.35% | 2.85 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.83 | 2.80 | 3.02 | 2.87 | 2.86 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.75 | 2.97 | 0.22 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,145 | 305,706 | $ 2.91 | $ 890,937 | 1,428,459 | 1.35 - 7.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:56:54 | 10 | $ 2.91 | USD |
Acer Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 39.67M | 13.92M | 9.12M | $ - | $ - | -2.91 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.09 | 3.1699 | 2.80 | 2.96 | 287,442 | -0.24 | -7.77% |
| 1 Month | 3.52 | 4.40 | 2.80 | 3.57 | 776,034 | -0.67 | -19.03% |
| 3 Months | 4.23 | 5.39 | 2.50 | 3.87 | 952,177 | -1.38 | -32.62% |
| 6 Months | 2.91 | 5.39 | 2.30 | 3.71 | 778,038 | -0.06 | -2.06% |
| 1 Year | 2.07 | 7.05 | 1.35 | 3.70 | 540,803 | 0.78 | 37.68% |
| 3 Years | 19.48 | 34.10 | 1.08 | 4.94 | 238,980 | -16.63 | -85.37% |
| 5 Years | 8.55 | 34.10 | 1.08 | 5.18 | 205,851 | -5.70 | -66.67% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
